Term ends Oct 25, 2033 · Low confidence
20-year base term ends Oct 25, 2033
Held by Bioverativ USA Inc.
Filed Dec 20, 2021 as application 17/556,061 · Granted Feb 4, 2025
Base term, 20 years from filing
Today
2013
2033
Clock starts
Oct 25, 2013
Oct 25, 2013
Term ends
Oct 25, 2033
Oct 25, 2033
Granted
Feb 4, 2025
Feb 4, 2025
base term
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,457,745, US 9,512,233, US 9,562,106, to Oct 25, 2033. The term already ends on or before that date, so the cap shortened nothing.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 2 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 25, 2013, when application PCT/US2013/066783, the earliest non-provisional in its chain, was filed (this one was filed Dec 20, 2021); a parent in its chain could not be resolved (the next row) | Oct 25, 2033 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,457,745, US 9,512,233, US 9,562,106) | resolves to Oct 25, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: PCTUS2013066783, PCTUS2013066783, PCTUS2013066783, PCTUS2013066783 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Oct 25, 2033 | Low confidence |
Partial family
| Application PCT/US2013/066783 | PCT application no patent term | no patent term |
| US 9,562,106 | In force Oct 2033 | Oct 2033 |
| US 9,512,233 | In force Oct 2033 | Oct 2033 |
| US 10,457,745 | In force Oct 2033 | Oct 2033 |
| Application 16/575,265 | Abandoned not computed | not computed |
| US 12,215,169 | this patent Oct 2033 | Oct 2033 |
| Application 18/989,593 | Pending not computed | not computed |
Partial: 1 of the 7 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 24, 2022 Reel 59384, frame 761 | Van Vlasselaer, Peter; Parry, Graham; Stagliano, Nancy E.; Panicker, Sandip | True North Therapeutics, Inc. | Assignment of Assignor's Interest |
| Mar 24, 2022 Reel 59488, frame 959 | True North Therapeutics, Inc. | Bioverativ USA Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2033
Term ends Oct 25, 2033. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,457,745, US 9,512,233, US 9,562,106, ends no earlier than this term, so it caps nothing.
Citations
3
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.